Sign in
4

Changes in Ownership

BeOne Medicines Ltd. Filed Acc 0001662982-26-000002

Director sold 38,287 shares at an average $349.10 ($13,366,092)

  • Director acquired 31,027 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Wang Xiaodong · Director

Table I: Non-derivative

9 lines
Date Transaction Shares Price Value Owned after D/I
2026-09-08 Sale : show line 1 in the form 10b5-1 −1,181 $345.38 $407,897 6,079 D
2026-09-08 Sale : show line 2 in the form 10b5-1 −2,841 $346.16 $983,433 3,238 D
2026-09-08 Sale : show line 3 in the form 10b5-1 −1,517 $347.39 $526,993 1,721 D
2026-09-08 Sale : show line 4 in the form 10b5-1 −1,721 $348.01 $598,930 0 D
2026-09-08 Exercise or conversion : show line 5 in the form 10b5-1 +31,027 $36.90 $1,144,896 31,027 D
2026-09-08 Sale : show line 6 in the form 10b5-1 −7,492 $348.31 $2,609,573 23,535 D
2026-09-08 Sale : show line 7 in the form 10b5-1 −10,688 $349.28 $3,733,141 12,847 D
2026-09-08 Sale : show line 8 in the form 10b5-1 −6,569 $350.27 $2,300,951 6,278 D
2026-09-08 Sale : show line 9 in the form 10b5-1 −6,278 $351.25 $2,205,174 0 D
Open-market sales · 38,287 sh · avg $349.10 · $13,366,092

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-09-08 Exercise or conversion : show line 10 in the form 10b5-1 Share Option (Right to Buy) −403,351 1,210,079 D
Loading xslF345X06/wk-form4_1789073392.xml…